Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Postma

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2023
Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital settingJob F H Eijsink, Mia Weiss, Ashley Taneja, et al.
Vaccine|August 7, 2023
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in EuropeAnnie Chicoye, Pascal Crépey, Van Hung Nguyen, et al.
Pharmacoeconomics|February 27, 2015
Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?Saskia Schawo, Annemarie van der Kolk, Clazien Bouwmans, et al.
Pharmacoeconomics|November 19, 2015
Use of Value of Information in Healthcare Decision Making: Exploring Multiple PerspectivesJill Bindels, Bram Ramaekers, Isaac Corro Ramos, et al.
Infectious Diseases and Therapy|June 24, 2018
Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in CanadaMichele Wilson, Matt Wasserman, Taj Jadavi, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 25, 2021
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studiesMark H Rozenbaum, Andrea Garcia, Daniel Grima, et al.
Frontiers in Public Health|August 16, 2023
Stakeholders' views and experiences on implementing new diagnostics in primary care to support management of community-acquired acute respiratory tract infections: a qualitative studyMelanie Eugenie Hoste, Elien Colman, Marta Wanat, et al.
Pharmacoeconomics|September 22, 2017
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related ResearchThea van Asselt, Bram Ramaekers, Isaac Corro Ramos, et al.
Vaccine|July 3, 2019
Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory diseaseRobertus van Aalst, Ellyn M Russo, Nabin Neupane, et al.
Vaccines|April 30, 2021
COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for TurkeyArnold Hagens, Ahmet Çağkan İnkaya, Kasirga Yildirak, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2023
Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital settingJob F H Eijsink, Mia Weiss, Ashley Taneja, et al.
Vaccine|August 7, 2023
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in EuropeAnnie Chicoye, Pascal Crépey, Van Hung Nguyen, et al.
Pharmacoeconomics|February 27, 2015
Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?Saskia Schawo, Annemarie van der Kolk, Clazien Bouwmans, et al.
Pharmacoeconomics|November 19, 2015
Use of Value of Information in Healthcare Decision Making: Exploring Multiple PerspectivesJill Bindels, Bram Ramaekers, Isaac Corro Ramos, et al.
Infectious Diseases and Therapy|June 24, 2018
Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in CanadaMichele Wilson, Matt Wasserman, Taj Jadavi, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 25, 2021
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studiesMark H Rozenbaum, Andrea Garcia, Daniel Grima, et al.
Frontiers in Public Health|August 16, 2023
Stakeholders' views and experiences on implementing new diagnostics in primary care to support management of community-acquired acute respiratory tract infections: a qualitative studyMelanie Eugenie Hoste, Elien Colman, Marta Wanat, et al.
Pharmacoeconomics|September 22, 2017
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related ResearchThea van Asselt, Bram Ramaekers, Isaac Corro Ramos, et al.
Vaccine|July 3, 2019
Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory diseaseRobertus van Aalst, Ellyn M Russo, Nabin Neupane, et al.
Vaccines|April 30, 2021
COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for TurkeyArnold Hagens, Ahmet Çağkan İnkaya, Kasirga Yildirak, et al.
Pageof 10